Filter posts

Jim Greenwood in WSJ: Curing Hepatitis C Is Cheaper Than Open-Ended Care

On Friday, a letter from BIO President and CEO Jim Greenwood was published in the …

Delivering on Biotech’s Promise to Treat Anthrax, Smallpox, Ebola

Thanks to federal biodefense programs that partner with industry to develop and stockpile medical countermeasures, …

Greenwood Highlights Need for Bold Action to Address Alzheimer's

Last week, Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), participated and …